2.14
price up icon1.18%   0.025
pre-market  시장 영업 전:  2.14  
loading
전일 마감가:
$2.115
열려 있는:
$2.11
하루 거래량:
246.62K
Relative Volume:
1.77
시가총액:
$28.07M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+29.70%
1개월 성능:
+134.83%
6개월 성능:
-52.44%
1년 성능:
+0.00%
1일 변동 폭
Value
$2.00
$2.15
1주일 범위
Value
$1.61
$2.22
52주 변동 폭
Value
$0.69
$9.55

Scienture Holdings Inc Stock (SCNX) Company Profile

Name
명칭
Scienture Holdings Inc
Name
전화
(800) 261 0281
Name
주소
2420 BRUNELLO TRACE, LUTZ
Name
직원
19
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
SCNX's Discussions on Twitter

SCNX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Pharmaceutical Retailers icon
SCNX
Scienture Holdings Inc
2.14 21.64M 0 0 0 0.00
Pharmaceutical Retailers icon
WBA
Walgreens Boots Alliance Inc
11.52 9.96B 151.95B -5.78B 571.00M -6.69
Pharmaceutical Retailers icon
HITI
High Tide Inc
2.39 194.49M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
1.18 61.89M 0 0 0 0.00
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
3.41 65.89M 270.52M -6.08M 17.42M -0.2944

Scienture Holdings Inc 주식(SCNX)의 최신 뉴스

pulisher
04:26 AM

Is Scienture Holdings Inc. a good long term investmentExceptional gains - jammulinksnews.com

04:26 AM
pulisher
Jul 21, 2025

What analysts say about Scienture Holdings Inc. stockLightning-fast capital gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Scienture Holdings Inc. Stock Analysis and ForecastSuperior trading gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Scienture Holdings regains compliance with Nasdaq listing requirements - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Why did SCNX's Q2 2023 earnings exceed forecasts significantly? - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Scienture Holdings Inc. stock priceRapid market gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 16, 2025

Scienture regains Nasdaq compliance as stock price exceeds $1 By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Scienture regains Nasdaq compliance as stock price exceeds $1 - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - The Manila Times

Jul 16, 2025
pulisher
Jul 15, 2025

Why Scienture Holdings Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

How Scienture Holdings Inc. stock performs during market volatilityCapital Doubling Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Scienture Holdings Inc. stock price move sharplyHigh Return Intraday Picks - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Scienture Holdings Secures Indemnification for Leadership - The Globe and Mail

Jul 04, 2025
pulisher
Jul 03, 2025

Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly? - simplywall.st

Jul 03, 2025
pulisher
Jun 17, 2025

Scienture Holdings terminates equity line of credit ahead of product launch - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC | SCNX Stock Ne - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC - The Manila Times

Jun 17, 2025
pulisher
Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC | SCNX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Scienture Holdings, Inc. Terminates Equity Line of Credit to Focus on Launching FDA-Approved Arbli - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Scienture Terminates $310M Credit Line to Focus on Revolutionary Liquid Hypertension Drug Launch - Stock Titan

Jun 17, 2025
pulisher
May 23, 2025

Scienture appoints Hariharan, Mani as co-CEOs - MSN

May 23, 2025
pulisher
May 22, 2025

SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz

May 22, 2025
pulisher
May 22, 2025

Scienture Appoints Co-CEOs as Suren Ajjarapu Steps Down - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

SCIENTURE Announces Executive Leadership Transition | SCNX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

SCIENTURE Announces Executive Leadership Transition - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Scienture Holdings, Inc. Announces Leadership Transition as Suren Ajjarapu Steps Down as CEO and Chairman - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Scienture Names Two Pharma Veterans as Co-CEOs in Strategic Leadership Overhaul - Stock Titan

May 22, 2025
pulisher
May 19, 2025

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Scienture Holdings, Inc. Announces FDA Patent Listing for Arbli™, First FDA-Approved Liquid Losartan Formulation - Nasdaq

May 19, 2025
pulisher
May 19, 2025

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. - The Manila Times

May 19, 2025
pulisher
May 19, 2025

FDA Orange Book Milestone: First-Ever Liquid Losartan Secures Patent Protection Until 2041 - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Long-Term Bull Put Spread Provides Opportunities for ARM Bulls - The Globe and Mail

May 19, 2025
pulisher
May 14, 2025

ON Holding Surges, Leads High-End Retailers Into Reversal - The Globe and Mail

May 14, 2025
pulisher
May 12, 2025

Scienture Holdings: Q1 Earnings Snapshot - CTPost

May 12, 2025

Scienture Holdings Inc (SCNX) 재무 분석

Scienture Holdings Inc (SCNX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.36
price down icon 0.73%
$1.374
price up icon 1.03%
pharmaceutical_retailers SSY
$1.23
price up icon 6.03%
$3.41
price up icon 3.02%
$1.18
price up icon 16.83%
자본화:     |  볼륨(24시간):